Global Breast Biopsy Devices Market 2020-2024
SKU ID : TNV-15881885 | Publishing Date : 22-Jun-2020 | No. of pages : 120
Detailed TOC of Global Breast Biopsy Devices Market 2020-2024
• Executive Summaryo Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2019
o Market outlook: Forecast for 2019 - 2024
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Product
o Market segments
o Comparison by Product
o Biopsy needles and systems - Market size and forecast 2019-2024
o Biopsy image-guided systems - Market size and forecast 2019-2024
o Others - Market size and forecast 2019-2024
o Market opportunity by Product
• Market Segmentation by End-user
o Market segments
o Hospitals
o ASCs
o Breast cancer specialty centers and clinics
o Others
• Market Segmentation by Modality
o Market segments
o Stereotactic X-ray guided breast biopsy
o Ultrasound-guided breast biopsy
o MRI-guided breast biopsy
• Customer landscape
o Customer landscape
• Geographic Landscape
o Geographic segmentation
o Geographic comparison
o North America - Market size and forecast 2019-2024
o Europe - Market size and forecast 2019-2024
o Asia - Market size and forecast 2019-2024
o ROW - Market size and forecast 2019-2024
o Key leading countries
o Market opportunity by geography
o Market drivers
o Market challenges
o Market trends
• Vendor Landscape
o Overview
o Landscape disruption
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Argon Medical Devices Inc.
o Carestream Health Inc.
o Danaher Corp.
o FUJIFILM Holdings Corp.
o General Electric Co.
o Hologic Inc.
o Planmed Oy
o Scion Medical Technologies LLC
o Siemens Healthineers AG
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibit
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Key Finding 10
• 10: Parent market
• 11: Market characteristics
• 12: Offerings of vendors included in the market definition
• 13: Market segments
• 14: Global - Market size and forecast 2019 - 2024 ($ million)
• 15: Global market: Year-over-year growth 2019 - 2024 (%)
• 16: Five forces analysis 2019 & 2024
• 17: Bargaining power of buyers
• 18: Bargaining power of suppliers
• 19: Threat of new entrants
• 20: Threat of substitutes
• 21: Threat of rivalry
• 22: Market condition - Five forces 2019
• 23: Product - Market share 2019-2024 (%)
• 24: Comparison by Product
• 25: Biopsy needles and systems - Market size and forecast 2019-2024 ($ million)
• 26: Biopsy needles and systems - Year-over-year growth 2019-2024 (%)
• 27: Biopsy image-guided systems - Market size and forecast 2019-2024 ($ million)
• 28: Biopsy image-guided systems - Year-over-year growth 2019-2024 (%)
• 29: Others - Market size and forecast 2019-2024 ($ million)
• 30: Others - Year-over-year growth 2019-2024 (%)
• 31: Market opportunity by Product
• 32: End user - Market share 2019-2024 (%)
• 33: Comparison by End user
• 34: Hospitals - Market size and forecast 2019-2024 ($ million)
• 35: Hospitals - Year-over-year growth 2019-2024 (%)
• 36: ASCs - Market size and forecast 2019-2024 ($ million)
• 37: ASCs - Year-over-year growth 2019-2024 (%)
• 38: Breast cancer specialty centers and clinics - Market size and forecast 2019-2024 ($ million)
• 39: Breast cancer specialty centers and clinics - Year-over-year growth 2019-2024 (%)
• 40: Others - Market size and forecast 2019-2024 ($ million)
• 41: Others - Year-over-year growth 2019-2024 (%)
• 42: Market opportunity by End user
• 43: Other1 - Market share 2019-2024 (%)
• 44: Comparison by Other1
• 45: Stereotactic X-ray guided breast biopsy - Market size and forecast 2019-2024 ($ million)
• 46: Stereotactic X-ray guided breast biopsy - Year-over-year growth 2019-2024 (%)
• 47: Ultrasound-guided breast biopsy - Market size and forecast 2019-2024 ($ million)
• 48: Ultrasound-guided breast biopsy - Year-over-year growth 2019-2024 (%)
• 49: MRI-guided breast biopsy - Market size and forecast 2019-2024 ($ million)
• 50: MRI-guided breast biopsy - Year-over-year growth 2019-2024 (%)
• 51: Market opportunity by Other1
• 52: Customer landscape
• 53: Market share by geography 2019-2024 (%)
• 54: Geographic comparison
• 55: North America - Market size and forecast 2019-2024 ($ million)
• 56: North America - Year-over-year growth 2019-2024 (%)
• 57: Europe - Market size and forecast 2019-2024 ($ million)
• 58: Europe - Year-over-year growth 2019-2024 (%)
• 59: Asia - Market size and forecast 2019-2024 ($ million)
• 60: Asia - Year-over-year growth 2019-2024 (%)
• 61: ROW - Market size and forecast 2019-2024 ($ million)
• 62: ROW - Year-over-year growth 2019-2024 (%)
• 63: Key leading countries
• 64: Market opportunity by geography ($ million)
• 65: Impact of drivers and challenges
• 66: Vendor landscape
• 67: Landscape disruption
• 68: Industry risks
• 69: Vendors covered
• 70: Market positioning of vendors
• 71: Argon Medical Devices Inc. - Overview
• 72: Argon Medical Devices Inc. - Product and service
• 73: Argon Medical Devices Inc. - Key offerings
• 74: Argon Medical Devices Inc. - Key customers
• 75: Argon Medical Devices Inc. - Segment focus
• 76: Becton, Dickinson and Co. - Overview
• 77: Becton, Dickinson and Co. - Business segments
• 78: Becton, Dickinson and Co. - Key offerings
• 79: Becton, Dickinson and Co. - Key customers
• 80: Becton, Dickinson and Co. - Segment focus
• 81: Carestream Health Inc. - Overview
• 82: Carestream Health Inc. - Product and service
• 83: Carestream Health Inc. - Key offerings
• 84: Carestream Health Inc. - Key customers
• 85: Carestream Health Inc. - Segment focus
• 86: Danaher Corp. - Overview
• 87: Danaher Corp. - Business segments
• 88: Danaher Corp. - Key offerings
• 89: Danaher Corp. - Key customers
• 90: Danaher Corp. - Segment focus
• 91: FUJIFILM Holdings Corp. - Overview
• 92: FUJIFILM Holdings Corp. - Business segments
• 93: FUJIFILM Holdings Corp. - Key offerings
• 94: FUJIFILM Holdings Corp. - Key customers
• 95: FUJIFILM Holdings Corp. - Segment focus
• 96: General Electric Co. - Overview
• 97: General Electric Co. - Business segments
• 98: General Electric Co. - Key offerings
• 99: General Electric Co. - Key customers
• 100: General Electric Co. - Segment focus
• 101: Hologic Inc. - Overview
• 102: Hologic Inc. - Business segments
• 103: Hologic Inc. - Key offerings
• 104: Hologic Inc. - Key customers
• 105: Hologic Inc. - Segment focus
• 106: Planmed Oy - Overview
• 107: Planmed Oy - Product and service
• 108: Planmed Oy - Key offerings
• 109: Planmed Oy - Key customers
• 110: Planmed Oy - Segment focus
• 111: Scion Medical Technologies LLC - Overview
• 112: Scion Medical Technologies LLC - Product and service
• 113: Scion Medical Technologies LLC - Key offerings
• 114: Scion Medical Technologies LLC - Key customers
• 115: Scion Medical Technologies LLC - Segment focus
• 116: Siemens Healthineers AG - Overview
• 117: Siemens Healthineers AG - Business segments
• 118: Siemens Healthineers AG - Key offerings
• 119: Siemens Healthineers AG - Key customers
• 120: Siemens Healthineers AG - Segment focus
• 121: Currency conversion rates for US$
• 122: Research Methodology
• 123: Validation techniques employed for market sizing
• 124: Information sources
• 125: List of abbreviations